Get Started Banner

Here’s a guide to what to expect with your AMT®-RA procedure.

Take the first step, schedule a hassle-free consultation to determine if you’re a candidate for the AMT®-RA procedure Your treatment provider will provide you with the best suitable treatment.

IMPORTANT SAFETY INFORMATION                                                                                                                                                   EXPAND +

IMPORTANT SAFETY INFORMATION FOR AMT®-RA

Important Information

The content of this Website is intended for informational purposes only and should not be used as a substitute for advice provided by a qualified healthcare professional. The Website serves as a resource platform for clinicians to assist clinics in integrating AMT®-RA into their practice.

AMT®-RA is a procedural protocol developed by orthopedic surgeons, traumatologists & sports medicine specialists for sports rehabilitation & traumatology. This protocol uses a micrografting device Rigenera® Manufactured by HBW a medical device manufacturing company committed to designing and manufacturing medical products of the highest quality. HBW has received ISO13485:2016 certification for the quality management system. This medical device is a regulated healthcare product, which under European regulations bears the CE mark.

Safety Information

AMT®-RA procedure is not for everyone. You should not have the AMT®-RA treatment in areas with metal, electrical, or electronic implants/devices.

Tell your doctor if you have any medical conditions as AMT®-RA should not be used in patients with fever, malignant tumor, hemorrhagic conditions, epilepsy, recent surgical procedure, pulmonary insufficiency, pregnancy, arthritis rheumatoid (positive rheumatoid factor), family-related inflammatory arthritis, hematoma auris (or “cauliflower ear”), other inflammatory general diseases which are not controlled., any autoimmune disease not controlled, ear reconstruction or otoplasty, knee infection or active synovitis, present articular fibrosis, meniscopathy.

AMT®-RA should not be used in patients with Graves’ disease (an autoimmune disorder that causes overactive thyroid), active bleeding disorders, or seizure disorders.

Common side effects may include, but may not be limited to, muscular pain, temporary muscle spasms, temporary joint or tendon pain, and redness at or near the treatment site.

Ask your Healthcare Provider if AMT®-RA is right for you.

Patient Results May Vary.

This site is for visitors from Europe, the Middle East, Asia, and Africa. The third-party trademarks used herein are trademarks of their respective owners.

©2023 Regenera Activa Worldwide, All rights reserved.

Become a certified AMT®-RA Physician.

Get Started

error: Content is protected !!